Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly
- 12 septembre 2024 - 1 mn de lecture
The objectives of the protocol is to determine the maximum tolerated dose and to investigate the pharmacokinetics of a single dose of lanreotide PRF in subjects with acromegaly.
12 septembre 2024
1 mn de lecture
An Open-Label Extension Study of Palovarotene to Prevent Heterotopic Ossification in People With Fibrodysplasia Ossificans Progressiva (FOP) in France
12 septembre 2024
1 mn de lecture
An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)
12 septembre 2024
1 mn de lecture
Evaluation of Palovarotene Concentration in Semen of Healthy Men after Multiple Oral Doses
12 septembre 2024
1 mn de lecture
A Thorough QT Study Evaluating the Effect of a Therapeutic and a Supratherapeutic Dose of Palovarotene on Electrocardiogram Parameters
12 septembre 2024
1 mn de lecture
Study Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on the Pharmacokinetics of the CYP3A4 Substrate Midazolam in...
12 septembre 2024
1 mn de lecture
68Ga-OPS202 Study for Diagnostic Imaging of GEP NET
12 septembre 2024
1 mn de lecture
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
12 septembre 2024
1 mn de lecture
Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency
12 septembre 2024
1 mn de lecture
Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma
12 septembre 2024
1 mn de lecture